A novel strategy for encapsulating poorly soluble drug into nanostructured lipid carriers for intravenous administration

Pharmaceutical Development and Technology

Volumn 17, Issue 4, 2012, Pages 443-456

  Zhao, Chunyan ^a   Liu, Yan ^a   Fan, Tingting ^a   Zhou, Dan ^a   Yang, Yang ^a   Jin, Yun ^a   Zhang, Zhirong ^a   Huang, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Dexamethasone; Nanostructured lipid carriers; Phospholipids complex; Physical stability; Spherical symmetric design surface response methodology

Indexed keywords

DEXAMETHASONE; NANOCOATING; PHOSPHOLIPID;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; PARTICLE SIZE; PRIORITY JOURNAL; X RAY DIFFRACTION; ZETA POTENTIAL;

ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG CARRIERS; DRUG STABILITY; INJECTIONS, INTRAVENOUS; NANOSTRUCTURES; PARTICLE SIZE; PHOSPHOLIPIDS; SOLUBILITY;

EID: 84862293288     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2010.546411     Document Type: Article

References (28)

1. Lipinski CA.Poor aqueous solubility - an industry wide problem in drug discovery.Am Pharm Rev 2002;5:82-85.
2. Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, Rabinow B, Kipp J, Ning J.Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects.Adv Drug Deliver Rev 2008;60:939-954.
3. Brewster ME, Loftsson T.Cyclodextrins as pharmaceutical solubilizers.Adv Drug Deliver Rev 2007;59:645-666.
4. Blanco E, Kessinger CW, Sumer BD, Gao J.Multifunctional micellar nanomedicine for cancer therapy.Exp Biol Med 2009; 234(2):123-131.
5. Agarwal A, Lvov Y, Sawant R, Torchilin V.Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology.J Contr Rel 2008;128:255-260.
6. Wissing SA, Kayser O, Muller RH.Solid lipid nanoparticles for parenteral drug delivery.Adv Drug Deliver Rev 2004;56: 1257-1272.
7. Lu W, He LC, Wang CH, Li YH, Zhang SQ.The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice.Int J Biol Macromol 2008;43(3):320-324.
8. Kaur IP, Bhandari R, Bhandari S, Kakkar V.Potential of solid lipid nanoparticles in brain targeting.J Contr Rel 2008;127: 97-109.
9. Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K.Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.J Contr Rel 2004;95:217-227.
10. Bialecka M.The Effect of bioflavonoids and lecithin on the course of experimental atherosclerosis in rabbits.Annu Acad Med Stein 1997;43:41-43.
11. Bhardwaj U, Burgess DJ.Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone.Int J Pharma 2010;388:181-189.
12. China Pharmacopeial Convention.Chinese Pharmacopoeia.Beijing: China medical science and technology press, 2010;2:249.
13. Kang LY.TLC identification for tabella prednisoni acetatis and tabella dexamethasoni acetates.Strait Pharma J 2005;17:62-63.
14. Qin X, Yang Y, Fan TT, Gong T, Zhang XN, Huang Y.Preparation, characterization and in vivo evaluation of bergenin-phospholipid complex.Acta Pharmacol Sin 2010;31:127-136.
15. Zhao XL, Yang CR, Yang KL, Li KX, Hu HY, Chen DW.Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.Drug Dev Ind Pharm.2010;36(7):773-80.
16. Boddu SHS, Jwala J, Vaishya R, Earla R, Karla PK, Pal D, Mitra AS.Novel Nanoparticulate Gel Formulations of Steroids for the Treatment of Macular Edema.J Ocul Pharmacol Th 2010;26:37-48.
17. Xiao YY, Song YM, Chen ZP, Ping QN.The preparation of silybin- phospholipid complex and the study on its pharmacokinetics in rats.Int J Pharm 2006;307:77-82.
18. Liang N, Shi K, Wang YS, Yu YW, Feng LL, Cui FD.Preparation and characterization of ferulic acid-phospholipid complex.J Shenyang Pharm University 2008;25:163-168.
19. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee P K.Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats.Int J Pharm 2007;330:155-163.
20. Cui FD, Shi K, Zhang LQ, Tao AJ, Kawashima Y.Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation.J Contr Rel 2006;114:242-250.
21. Nekahi A, Dehghani K.Modeling the thermomechanical effects on baking behavior of low carbon steels using response surface methodology.Mater and Des 2010;31:3845-3851.
22. Gaete CG, Tsapis N, Besnard M, Bochot A, Fattal E.Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.Int J Pharm 2007;331:153-159.
23. Wei W, Shi SJ, Liu J, Sun X, Ren K, Zhao D, Zhang XN, Zhang ZR, Gong T.Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.J Drug Target 2010;18:557-566.
24. Teeranachaideekul V, Boonme P, Souto EB, Muller RH, Junyaprasert VB.Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC.J Contr Rel 2008;128:134-141.
25. Jores K, Mehnert W, Mäder K.Physicochemical Investigations on Solid Lipid Nanoparticles and on Oil-Loaded Solid Lipid Nanoparticles: A Nuclear Magnetic Resonance and Electron Spin Resonance Study.Pharm Res 2003;20(8):1274-1283.
26. Yang CR, Zhao XL, Hu HY, Li KX, Sun X, Li L, Cheng DW.Preparation, Optimization and Characteristic of Huperzine A Loaded Nanostructured Lipid Carriers.Chem Pharm Bull 2010;58(5):656-661.
27. Doktorovova S, Souto EB.Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review.Expet Opin Drug Deliv 2009;6(2):165-176.
28. Lim SJ, Kim CK.Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid.Int J Pharm 2002;243: 135-146.